As of March 1, 2016, AmeriHealth has new preferred providers for both
our Direct Ship Drug Program and intravenous and subcutaneous immunoglobulin
(IVIG/SCIG) drugs provided in the home. These changes do not affect medical
necessity criteria or coverage determinations for our members.
Direct Ship Drug Program
Walgreens and PerformSpecialty (referred to in previous AmeriHealth
communications as PerformRx) were chosen as preferred providers for our Direct
Ship Drug Program. All requests for direct ship drugs will be fulfilled by
these providers, with the exception of Synagis®, which will
continue to be fulfilled by ACRO Pharmaceutical Services.
For more information on ordering drugs through our Direct Ship Drug Program,
go to the AmeriHealth New Jersey webpage
or the AmeriHealth Pennsylvania webpage.
IVIG/SCIG home infusion
Option Care was selected as the preferred provider for IVIG/SCIG drugs given
in the home.
The following communications occurred for this change:
- AmeriHealth sent letters to affected members notifying them that Option
Care is the preferred home infusion vendor for IVIG/SCIG and detailing the
transition plan of service.
- Option Care provided outreach to affected members to answer questions and
schedule appointments with an Option Care home infusion nurse.
- Option Care contacted affected vendors to answer questions and obtain new
prescriptions for our members.
Members who start home infusion therapy with IVIG/SCIG drugs on or after
March 1, 2016, should receive such services from either Option Care or a home
infusion vendor that is owned by a hospital or health system that participates
in the AmeriHealth provider network.
Providers should talk to their AmeriHealth members who currently receive
IVIG/SCIG drugs at home to see if they have any questions or concerns.
Note: Members who currently receive IVIG/SCIG drugs through home
infusion vendors that are owned by a hospital or health system that
participates in the AmeriHealth provider network are not affected by this
change.